ReachRxResearch
Home
Research
Sign Up
Epitope-diverse autoantibodies induce neutrophil–epithelial niches driving kidney injury in ANCA-associated glomerulonephritis
Back to Research Hub
  1. Home
  2. Research Hub
  3. Epitope-diverse autoantibodies induce ne…

Epitope-diverse autoantibodies induce neutrophil–epithelial niches driving kidney injury in ANCA-associated glomerulonephritis

Journal of Experimental Medicine·October 19Open Access
ImmunologyPractice changingANCA-Associated GlomerulonephritisMicroscopic PolyangiitisTranslational Study (Spatial Transcriptomics + Mouse Model)FcγR Inhibitor (Engineered Antibody)Monoclonal AntibodyOlder AdultXenium (10x Genomics)Myeloperoxidase-ANCA

Summary

View source

What was studied

Using single-cell–resolved spatial transcriptomics (10x Genomics Xenium, 5,000-gene panel) on kidney biopsies from 8 treatment-naïve MPO-ANCA–positive microscopic polyangiitis patients and 4 healthy donors, this study mapped how epitope-diverse anti-MPO autoantibodies organize pathogenic neutrophil–epithelial niches driving glomerulonephritis, and tested whether one-armed anti-MPO antibodies engineered to minimize FcγR engagement could attenuate kidney injury in mouse models.

Key findings

Spatial profiling identified early peri-glomerular niches of HAVCR1+ injured proximal tubular epithelial cells secreting CXCL6 and CXCL16 that recruited FcγR-high, type II interferon–enriched neutrophils; combinations of 3 monoclonal anti-MPO antibodies targeting distinct MPO epitopes (mAb-A24, mAb-A46, mAb-B88) synergistically enhanced neutrophil ROS production and NET formation and induced pauci-immune crescentic glomerulonephritis in mice, while one-armed variants of these antibodies significantly reduced urinary albumin-to-creatinine ratios and crescent formation (P<0.01) in a passive-transfer AAV model.

Study limitations

Human biopsy data are cross-sectional, so pseudotime trajectories are computational inferences rather than true temporal sequences; the antibody-induced mouse model relies on 129S6 mice with strain-specific heightened neutrophil reactivity, limiting generalizability; the three one-armed antibodies do not cover the full polyclonal anti-MPO repertoire, so therapeutic breadth in human disease is uncertain.

Clinical implications

FcγR-dependent neutrophil activation driven by epitope-diverse anti-MPO antibodies appears central to early glomerular injury in ANCA-associated vasculitis, suggesting that disrupting FcγR engagement—rather than simply neutralizing MPO binding—may be a tractable therapeutic strategy. Patients whose MPO-ANCA recognizes multiple epitopes (Hb/Hc regions) had significantly higher Birmingham Vasculitis Activity Scores, which may help stratify disease severity at diagnosis.

Caveats

  • Mouse disease induction required strain-specific (129S6) heightened neutrophil reactivity, which may overestimate therapeutic effect sizes seen with one-armed antibodies
  • Multi-epitope recognition was associated with higher BVAS in only 9 of 23 patients; this subgroup analysis is underpowered and should be interpreted cautiously
  • Partial industry involvement (Chugai Pharmaceutical) in study design, antibody engineering, and analysis is a potential source of bias
Show all 4
  • The human cohort is small (n=8 patients) and from a single center in Japan, where MPO-ANCA predominates; findings may not fully generalize to PR3-ANCA or ethnically diverse populations

Related Questions

Explore related topics

How does epitope diversity of MPO-ANCA antibodies affect disease severity and outcomes in ANCA-associated vasculitis?What is the role of FcγR signaling in neutrophil activation and kidney injury in ANCA-associated glomerulonephritis?What therapeutic strategies targeting neutrophil activation are being investigated for MPO-ANCA vasculitis?

Publication Details

Year
2026
Journal
Journal of Experimental Medicine
Sample Size
n=12
Source
View article
Keep scrolling
More content below.
Up Next